| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/20/2002 | EP1180037A2 Therapeutic uses of agents that modulate the activity of alpha-smooth muscle actin |
| 02/20/2002 | EP1180016A2 Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases |
| 02/20/2002 | EP0832120B1 Anti-fungal d-amino acid histatin-based peptides |
| 02/20/2002 | EP0792286B1 Peptide analogues at position 91 of human myelin basis protein for treatment of multiple scerosis |
| 02/20/2002 | EP0749485B1 Antimicrobial proteins from impatiens |
| 02/20/2002 | EP0667904B1 Suppressor and progenitor cells |
| 02/20/2002 | EP0567613B1 Compositions for therapy and prevention of cancer |
| 02/20/2002 | CN1336957A BASB006 polynucleotide(s) and polypeptides from neisseria meningitis |
| 02/20/2002 | CN1336935A Compositions and methods for WT1 specific immunotherapy |
| 02/20/2002 | CN1336934A Bis-amino acid sulfonamides containing N-terminally a substituted benzyl group as HIV protease inhibitors |
| 02/20/2002 | CN1336386A Giant web bombinator polypeptide and its prepn. and pharmaceutical application |
| 02/20/2002 | CN1336385A Giant well bombinator proteinase inhibitor and its prepn. and pharmaceutical application |
| 02/20/2002 | CN1336384A Giant web bombinator skin peptide and its prepn. and pharmaceutical application |
| 02/20/2002 | CN1336383A Giant web bombinin and its prepn. and pharmaceutical application |
| 02/20/2002 | CN1336382A Endothelial cell growth resisting engineered protein |
| 02/20/2002 | CN1336381A Trichosanthin mutant and its prepn. |
| 02/20/2002 | CN1336380A Anticancer polypeptide |
| 02/20/2002 | CN1336178A Prepn. of blood coagulation factor IX compound |
| 02/20/2002 | CN1336168A Oxidation compositions used for dyeing, long term shaping and bleaching keratin fiber |
| 02/20/2002 | CN1336127A Prepn. and use of enzymolyzed buckwheat protein product |
| 02/19/2002 | US6348585 Amino acid sequence; treatment and diagnosis of cardiovascular, nervous system, and psychological disorders; antiulcer agents; hypotensive/hypertensive agents |
| 02/19/2002 | US6348584 Fibronectin binding protein compounds |
| 02/19/2002 | US6348582 Prokaryotic polynucleotides polypeptides and their uses |
| 02/19/2002 | US6348579 FtsL |
| 02/19/2002 | US6348578 Apt |
| 02/19/2002 | US6348577 Regulation of aureobasidin sensitivity in fungus |
| 02/19/2002 | US6348576 Human cornichon molecule |
| 02/19/2002 | US6348574 An antibody; diagnosis and therapy for tumors, strokes, vasoconstriction, bronchial asthma, and atherosclerosis |
| 02/19/2002 | US6348571 Corticotropin release inhibiting factor and methods of using same |
| 02/19/2002 | US6348568 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 02/19/2002 | US6348567 A peptide derived from streptokinase; therapy for nervous system disorders, cardiovascular diseases, autoimmune diseases, parkinson's/alzheimer's/huntington's diseases and inflammatory diseases |
| 02/19/2002 | US6348503 Conditioning treatment for herpes sores using powder form using echinacea |
| 02/19/2002 | US6348448 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors |
| 02/19/2002 | US6348447 Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein |
| 02/19/2002 | US6348445 Biologically active peptides with reduced toxicity in animals and a method for preparing same |
| 02/19/2002 | US6348444 Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans |
| 02/19/2002 | US6348352 Purging tumor cells from a hematopoietic progenitor cell population by introducing a stable tumor suppressor gene into a heterogeneous cell population and selectively transducing phenotypically hyperproliferative cells |
| 02/19/2002 | US6348351 Tie receptor tyrosine kinase ligand homologues |
| 02/19/2002 | US6348344 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same |
| 02/19/2002 | US6348340 Compounds |
| 02/19/2002 | US6348335 Metabolism active materials, heating and cooling yeasts then isolation |
| 02/19/2002 | US6348333 VEGF-binding KDR polypeptide |
| 02/19/2002 | US6348329 Isolation of polynucleotide sequence codes of polypeptide with amino acid sequences |
| 02/19/2002 | US6348221 Avoiding or reducing damage to intestinal mucosa and resultant diarrhea by administering to patient with cancer effective amount of substance isolated from germinated seed of barley, rice or rye plant |
| 02/19/2002 | US6348214 Materials and methods for making improved liposome compositions |
| 02/19/2002 | US6348213 Intravenously administering liposomes having lipid component comprising phosphatidylcholine having same acyl chains as phosphatidylcholines in heart cells of younger subjects, repeating until drop in serum creatine phosphokinase is noted |
| 02/19/2002 | US6348207 Exposing biologically active agent to complexing perturbant to reversibly transform biologically active agent to intermediate state and form orally deliverable supramolecular complex, orally administering complex to subject |
| 02/19/2002 | US6348192 Interleukin-2 mutein expressed from mammalian cells |
| 02/19/2002 | US6348191 Production and use of IL-6 |
| 02/19/2002 | US6348185 Functional moiety linking peptide to diagnostic or pharmaceutically active substance and which confers target cell specificity to said compound; radiotherapy and drug delivery; conjugate coordination and covalent complexes; |
| 02/19/2002 | US6348042 Bioactive shunt |
| 02/19/2002 | US6347633 Treatment of hepatitis C using hyperthermia |
| 02/19/2002 | CA2195065C Inhalation composition |
| 02/19/2002 | CA2182030C Use of a bradykinin antagonist in a cosmetic, pharmaceutical or dermatological composition; composition thus obtained |
| 02/19/2002 | CA2126135C Use of human protein c for prevention and treatment of depositions of thrombocytes |
| 02/19/2002 | CA2103889C Process for the phosphorylation of insulin and product produced thereby |
| 02/19/2002 | CA2085953C Human antithrombin-iii preparation |
| 02/19/2002 | CA2039387C Heat-treated igm antibody preparations |
| 02/19/2002 | CA2023246C Mutants of human interleukin-3 |
| 02/19/2002 | CA2017217C Amino acid derivative anticonvulsant |
| 02/14/2002 | WO2002012899A2 Peptides presented by cells |
| 02/14/2002 | WO2002012887A2 Methods and compositions for the diagnosis and treatment of brown adipose cell disorders |
| 02/14/2002 | WO2002012539A2 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 02/14/2002 | WO2002012537A2 Mutant trichosanthin |
| 02/14/2002 | WO2002012524A2 Adenovirus e1b-55k single amino acid mutants and methods of use |
| 02/14/2002 | WO2002012510A1 A novel polypeptide, a nad-dependent 2-hydroxy acid dehydrogenase family protein 11 and the polynucleotide encoding the polypeptide |
| 02/14/2002 | WO2002012507A1 A NOVEL POLYPEPTIDE, A HUMAN AMINOACYL-tRNA SYNTHETASE 29 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE |
| 02/14/2002 | WO2002012506A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 02/14/2002 | WO2002012502A2 Anti-tnf antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012501A2 Anti-dual integrin antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012500A2 Anti-il-12 antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012495A1 Protein induced by homogeneous blood transfusion and dna encoding the same |
| 02/14/2002 | WO2002012489A1 A novel polypeptide- human zinc finger protein 44 and the polynucleotide encoding said polypeptide |
| 02/14/2002 | WO2002012488A1 A novel polypeptide- zinc finger protein 8.8 and the polynucleotide encoding said polypeptide |
| 02/14/2002 | WO2002012479A2 Zcys9: a member of the cystatin superfamily |
| 02/14/2002 | WO2002012476A2 Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| 02/14/2002 | WO2002012469A2 A human adenylate kinase family member and uses therefor |
| 02/14/2002 | WO2002012467A2 Drug metabolizing enzymes |
| 02/14/2002 | WO2002012461A2 Regulation of human membrane-type serine protease |
| 02/14/2002 | WO2002012460A2 Isolation of a human amine oxidase-like protein |
| 02/14/2002 | WO2002012458A1 A new polypeptide-human non-integration protein-metalloprotease 11.11 and the polynucleotide encoding it |
| 02/14/2002 | WO2002012457A1 A new polypeptide-human protein phosphatase 13.31 and the polynucleotide encoding it |
| 02/14/2002 | WO2002012456A2 Ampk-related serine/threonine kinase, designated snark |
| 02/14/2002 | WO2002012439A2 Genes associated with renal disease |
| 02/14/2002 | WO2002012347A1 Immunotherapy for chronic myelocytic leukemia |
| 02/14/2002 | WO2002012346A2 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 02/14/2002 | WO2002012345A2 Soluble zcytor 11 cytokine receptors |
| 02/14/2002 | WO2002012343A2 Proteins and nucleic acids encoding g-protein coupled receptors |
| 02/14/2002 | WO2002012341A2 Her-2/neu fusion proteins |
| 02/14/2002 | WO2002012340A2 Transporters and ion channels |
| 02/14/2002 | WO2002012339A2 Sequences for integrin alpha-8 |
| 02/14/2002 | WO2002012337A1 Peptide mimetics |
| 02/14/2002 | WO2002012336A2 TGF-β THERAPEUTICS, COMPOSITIONS AND METHODS OF USE |
| 02/14/2002 | WO2002012334A2 Snake venom polypeptide zsnk1 |
| 02/14/2002 | WO2002012333A1 Potential growth factors from the human tumour cell line ht1080 |
| 02/14/2002 | WO2002012331A2 Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| 02/14/2002 | WO2002012329A2 Compositions and methods for the therapy and diagnosis of head and neck cancer |
| 02/14/2002 | WO2002012328A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 02/14/2002 | WO2002012327A2 Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| 02/14/2002 | WO2002012326A2 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |